BAG3 promotes pancreatic ductal adenocarcinoma growth by activating stromal macrophages

Nature Communications

Volumn 6, Issue , 2015, Pages

  Rosati, Alessandra ^a,b   Basile, Anna ^a,b   DAuria, Raffaella ^a,c   DAvenia, Morena ^a   De Marco, Margot ^a   Falco, Antonia ^a,c   Festa, Michelina ^a,c   Guerriero, Luana ^a,c   Iorio, Vittoria ^a,b   Parente, Roberto ^a   Pascale, Maria ^a,c   Marzullo, Liberato ^a,b   Franco, Renato ^d   Arra, Claudio ^d   Barbieri, Antonio ^d   Rea, Domenica ^d   Menichini, Giulio ^e   Hahne, Michael ^f   Bijlsma, Maarten ^g   Barcaroli, Daniela ^h   Sala, Gianluca ^h   Di Mola, Fabio Francesco ⁱ   Di Sebastiano, Pierluigi ⁱ   Todoric, Jelena ^j   Antonucci, Laura ^j   Corvest, Vincent ^k   Jawhari, Anass ^k   Firpo, Matthew A ^l   Tuveson, David A ^m   Capunzo, Mario ^b   Karin, Michael ^j   De Laurenzi, Vincenzo ^a,h   Turco, Maria Caterina ^a,b   more..

^a BIOUNIVERSA Srl   (Italy)

^b UNIVERSITY OF SALERNO   (Italy)

^c UNIVERSITY OF SALERNO   (Italy)

^d NATIONAL CANCER INSTITUTE   (Italy)

^e CAREGGI UNIVERSITY HOSPITAL   (Italy)

^f INSTITUT DE GÉNÉTIQUE MOLÉCULAIRE DE MONTPELLIER   (France)

^g UNIVERSITY OF AMSTERDAM   (Netherlands)

^h UNIVERSITY OF CHIETI   (Italy)

ⁱ Ss Annunziata Hospital   (Italy)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k Calixar SAS   (France)

^l UNIVERSITY OF UTAH   (United States)

^m NONE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CELLS AND CELL COMPONENTS; DEVELOPMENTAL BIOLOGY; GROWTH; SECRETION; SIGNAL; TUMOR;

APOPTOSIS REGULATORY PROTEIN; BAG3 PROTEIN, HUMAN; BAG3 PROTEIN, MOUSE; FRAGILIS3 PROTEIN, MOUSE; IFITM2 PROTEIN, HUMAN; MEMBRANE PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ANIMAL; C57BL MOUSE; CELL PROLIFERATION; CYTOLOGY; FEMALE; GENETICS; HUMAN; MACROPHAGE; METABOLISM; MOUSE; PANCREAS CARCINOMA; PANCREAS TUMOR; PATHOPHYSIOLOGY; STROMA CELL;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; APOPTOSIS REGULATORY PROTEINS; CARCINOMA, PANCREATIC DUCTAL; CELL PROLIFERATION; FEMALE; HUMANS; MACROPHAGES; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; PANCREATIC NEOPLASMS; PHOSPHATIDYLINOSITOL 3-KINASES; STROMAL CELLS;

EID: 84946220080     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms9695     Document Type: Article

References (48)

1. Major, S. Deaths from pancreatic cancer in Europe continue to increase while rates for other cancers fall. BMJ 348, g2914 (2014).
2. Garrido-Laguna, I. & Hidalgo, M. Pancreatic cancer: from state-of-the-art treatments to promising novel therapies. Nat. Rev. Clin. Oncol. 12, 319-334 (2015).
3. Li, N., Grivennikov, S. I. & Karin, M. The unholy trinity: inflammation, cytokines, and STAT3 shape the cancer microenvironment. Cancer Cell 19, 429-431 (2011).
4. Erkan, M., et al. The role of stroma in pancreatic cancer: diagnostic and therapeutic implications. Nat. Rev. Gastroenterol. Hepatol. 9, 454-467 (2012).
5. Quail, D. F. & Joyce, J. A. Microenvironmental regulation of tumour progression and metastasis. Nat. Med. 19, 1423-1437 (2013).
6. Waghray, M., Yalamanchili, M., di Magliano, M. P. & Simeone, D. M. Deciphering the role of stroma in pancreatic cancer. Curr. Opin. Gastroenterol. 29, 537-543 (2013).
7. Gore, J. & Korc, M. Pancreatic cancer stroma: friend or foe? Cancer Cell 25, 711-712 (2014).
8. Helm, O., Held-Feindt, J., Schäfer, H. & Sebens, S. M1 and M2: There is no "good" and "bad" - How macrophages promote malignancy-associated features in tumourigenesis. Oncoimmunology 3, e946818 (2014).
9. Hermano, E., et al. Macrophage polarization in pancreatic carcinoma: role of heparanase enzyme. J. Natl. Cancer Inst. 106, dju332 (2014).
10. Karnevi, E., Andersson, R. & Rosendhal, A. H. Tumour-educated macrophages display a mixed polarization and enhance pancreatic cancer cell invasion. Immunol. Cell Biol. 92, 543-552 (2014).
11. Noy, R. & Pollard, J. W. Tumour-associated macrophages: from mechanisms to therapy. Immunity 41, 49-61 (2014).
12. Özdemir, B. C., et al. Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreatic cancer with reduced survival. Cancer Cell 25, 719-734 (2014).
13. Rhim, A. D., et al. Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma. Cancer Cell 25, 735-747 (2014).
14. Rowley, D. R. Reprogramming the tumour stroma: a new paradigm. Cancer Cell 26, 451-452 (2014).
15. Sherman, M. H., et al. Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy. Cell 25, 80-93 (2014).
16. Liou, G. Y., et al. Mutant KRAS-induced expression of ICAM-1 in pancreatic acinar cells causes attraction of macrophages to expedite the formation of precancerous lesions. Cancer Discov. 5, 52-63 (2015).
17. Rosati, A., et al. Expression of the antiapoptotic protein BAG3 is a feature of pancreatic adenocarcinoma and overexpression is associated with poorer survival. Am. J. Pathol. 181, 1524-1529 (2012).
18. Takayama, S., Xie, Z. & Reed, J. C. An evolutionarily conserved family of Hsp70/Hsc70molecular chaperone regulators. J. Biol. Chem. 274, 781-786 (1999).
19. De Maio, A. Extracellular Hsp70: export and function. Curr. Protein Pept. Sci. 15, 225-231 (2014).
20. Ammirante, M., et al. IKK{gamma} protein is a target of BAG3 regulatory activity in human tumour growth. Proc. Natl Acad. Sci. USA 107, 7497-7502 (2010).
21. Rosati, A., et al. BAG3: a multifaceted protein that regulates major cell pathways. Cell Death Dis. 2, e141 (2011).
22. Falco, A., et al. BAG3 controls angiogenesis through regulation of ERK phosphorylation. Oncogene 31, 5153-5161 (2012).
23. Falco, A., et al. BAG3 is a novel serum biomarker for pancreatic adenocarcinomas. Am. J. Gastroenterol. 108, 1178-1180 (2013).
24. Numrich, J. & Ungermann, C. Endocytic Rabs in membrane trafficking and signaling. Biol. Chem. 395, 327-3 (2014).
25. Li, N., et al. Loss of acinar cell IKKalpha triggers spontaneous pancreatitis mice. J. Clin. Invest. 123, 2231-2243 (2013).
26. Fukuda, A., et al. Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression. Cancer Cell 12, 441-455 (2011).
27. Lesina, M., et al. Stat3/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic inraepithelial neoplasia and development of pancreatic cancer. Cancer Cell 19, 456-469 (2011).
28. Zhang, Y., et al. Interleukin-6 is required for pancreatic cancer progression by promoting MAPK signaling activation and oxidative stress resistance. Cancer Res. 73, 6359-6374 (2013).
29. Schieven, G. L. The p38alpha kinase plays a central role in inflammation. Curr. Top. Med. Chem. 9, 1038-1048 (2009).
30. Senthil Kumar, A., et al. ESAT-6 induced COX-2 expression involved coordinated interplay between PI3K and MAPK signaling. Mol. Immunol. 49, 655-663 (2012).
31. Xu, N., et al. Activation of RAW264.7 mouse macrophage cells in vitro through treatment with recombinant ricin toxin-binding subunit B: involvement of protein tyrosine, NF-kB and JAK-STAT kinase signaling pathways. Int. J. Mol. Med. 32, 729-735 (2013).
32. Gentilella, A. & Khalili, K. BAG3 expression in glioblastoma cells promotes accumulation of ubiquitinated clients in an Hsp70-dependent manner. J. Biol. Chem. 286, 9205-9215 (2011).
33. Colvin, T. A., et al. Hsp70-Bag3 interactions regulate cancer-related signaling networks. Cancer Res. 74, 4731-4740 (2014).
34. Boj, S. F., et al. Organoid models of human and mouse ductal pancreatic cancer. Cell 160, 324-338 (2015).
35. Grivennikov, S. I., Greten, F. R. & Karin, M. Immunity, inflammation, and cancer. Cell 140, 883-899 (2010).
36. Cully, M. Cancer: targeting IL-17 in pancreatic cancer. Nat. Rev. Drug Discov. 13, 493 (2014).
37. Gore, A. J., Deitz, S. L., Palam, L. R., Craven, K. E. & Korc, M. Pancreatic cancer-associated retinoblastoma 1 dysfunction enables TGF-b to promote proliferation. J. Clin. Invest. 124, 338-352 (2014).
38. Lee, J. J., et al. Stromal response to Hedgehog signaling restrains pancreatic cancer progression. Proc. Natl Acad. Sci. USA 30, E3091-E30100 (2014).
39. McAllister, F., et al. Oncogenic Kras activates a hematopoietic-to-epithelial IL-17 signaling axis in preinvasive pancreatic neoplasia. Cancer Cell 25, 621-637 (2014).
40. Ouyang, H., Gore, J., Deitz, S. & Korc, M. microRNA-10b enhances pancreatic cancer cell invasion by suppressing TIP30 expression and promoting EGF and TGF-b actions. Oncogene 33, 4664-4674 (2014).
41. Trajkovic-Arsic, M., Kalideris, E. & Siveke, J. T. The role of insulin and IGF system in pancreatic cancer. J. Mol. Endocrinol. 50, R67-R74 (2013).
42. Rawnaq, T., et al. The multifunctional growth factor midkine promotes proliferation and migration in pancreatic cancer. Mol. Cancer Res. 12, 670-680 (2014).
43. Ray, K. C., et al. Heparin-binding epidermal growth factor-like growth factor eliminates constraints on activated Kras to promote rapid onset of pancreatic neoplasia. Oncogene 33, 823-831 (2014).
44. Wu, H. H., et al. Targeting IL-17B-IL-17RB signalling with an anti-IL-17RB antibody blocks pancreatic cancer metastasis by silencing multiple chemokines. J. Exp. Med. 212, 333-349 (2015).
45. Kim, S., et al. Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. Nature 457, 102-106 (2009).
46. Gao, C., et al. TLR9 signaling in the tumour microenvironment initiates cancer recurrence after radiotherapy. Cancer Res. 73, 7211-7221 (2013).
47. Diamond, M. S. & Farzan, M. The broad-spectrum antiviral functions of IFIT and IFITM proteins. Nat. Rev. Immunol. 13, 46-57 (2013).
48. Fontanella, B., et al. The co-chaperone BAG3 interacts with the cytosolic chaperonin CCT: new hints for actin folding. Int. J. Biochem. Cell Biol. 42, 641-650 (2010).